The University of Chicago Header Logo

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following properties of Blair, Elizabeth
PropertyValue
overview Elizabeth Blair, MD, is a highly regarded surgeon who specializes in head and neck surgery. Dr. Blair is an expert in the diagnosis and treatment of head and neck cancer, thyroid and parathyroid disease, salivary gland tumors and skull base tumors, as well as malignant melanoma and other skin cancers. She has a special interest in treating patients with voice and laryngeal disorders ranging from hoarseness to vocal cord paralysis. Dr. Blair's research interests include management of laryngeal and voice disorders, functional outcomes of patients treated for head and neck cancer and development of organ preservation therapies for head and neck malignancies. She also has an interest in early diagnosis and prevention of head and neck cancer.
One or more keywords matched the following items that are connected to Blair, Elizabeth
Item TypeName
Concept Head and Neck Neoplasms
Academic Article A phase I trial of docetaxel based induction and concomitant chemotherapy in patients with locally advanced head and neck cancer.
Academic Article Characteristics associated with swallowing changes after concurrent chemotherapy and radiotherapy in patients with head and neck cancer.
Academic Article Erlotinib and bevacizumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck: a phase I/II study.
Academic Article Epidermal growth factor receptor inhibitor gefitinib added to chemoradiotherapy in locally advanced head and neck cancer.
Academic Article Factors associated with long-term speech and swallowing outcomes after chemoradiotherapy for locoregionally advanced head and neck cancer.
Academic Article Prior chemoradiotherapy adversely impacts outcomes of recurrent and second primary head and neck cancer treated with concurrent chemotherapy and reirradiation.
Academic Article A randomized phase II study of 5-fluorouracil, hydroxyurea, and twice-daily radiotherapy compared with bevacizumab plus 5-fluorouracil, hydroxyurea, and twice-daily radiotherapy for intermediate-stage and T4N0-1 head and neck cancers.
Academic Article Airway management before chemoradiation for advanced head and neck cancer.
Academic Article Phase II trial of pemetrexed-based induction chemotherapy followed by concomitant chemoradiotherapy in previously irradiated patients with squamous cell carcinoma of the head and neck.
Academic Article Planned post-chemoradiation neck dissection: significance of radiation dose.
Academic Article A phase II study of lapatinib in recurrent/metastatic squamous cell carcinoma of the head and neck.
Academic Article Neck response to chemoradiotherapy: complete radiographic response correlates with pathologic complete response in locoregionally advanced head and neck cancer.
Academic Article Phase II study of gefitinib adaptive dose escalation to skin toxicity in recurrent or metastatic squamous cell carcinoma of the head and neck.
Academic Article Adjuvant chemotherapy prior to postoperative concurrent chemoradiotherapy for locoregionally advanced head and neck cancer.
Academic Article Head and neck cancer. The problem.
Academic Article A phase I dose escalation study of Ad GV.EGR.TNF.11D (TNFeradeā„¢ Biologic) with concurrent chemoradiotherapy in patients with recurrent head and neck cancer undergoing reirradiation.
Academic Article Upper airway complications of smoking.
Academic Article Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas.
Academic Article Comparison of outcomes of locoregionally advanced oropharyngeal and non-oropharyngeal squamous cell carcinoma over two decades.
Academic Article Lymph node density--prognostic value in head and neck cancer.
Academic Article Response-adapted volume de-escalation (RAVD) in locally advanced head and neck cancer.
Academic Article Final Results of a Randomized Phase 2 Trial Investigating the Addition of Cetuximab to Induction Chemotherapy and Accelerated or Hyperfractionated Chemoradiation for Locoregionally Advanced Head and Neck Cancer.
Academic Article A phase I dose escalation study of Ad GV.EGR.TNF.11D (TNFerade) with concurrent chemoradiotherapy in patients with recurrent head and neck cancer (HNC).
Academic Article Phase II trial pemetrexed-based induction chemotherapy followed by concomitant chemoradiotherapy in previously irradiated head and neck cancer patients.
Academic Article AHNS Series - Do you know your guidelines? Principles of treatment for glottic cancer: A review of the National Comprehensive Cancer Network guidelines.
Academic Article Effect of neuromuscular blockade on facial nerve monitoring.
Academic Article Phase I study of nab-paclitaxel-based induction followed by nab-paclitaxel-based concurrent chemotherapy and re-irradiation in previously treated head and neck squamous cell carcinoma.
Search Criteria
  • Head and Neck Cancer